US 10,888,643 B2
Negative pressure interbody device, system, and method
Thomas Zink, San Antonio, TX (US); Zeshan Hyder, Munster, IN (US); Frank Kuwamura, III, San Antonio, TX (US); and Nicholas Cordaro, Vista, CA (US)
Filed by Thomas Zink, San Antonio, TX (US); Zeshan Hyder, Munster, IN (US); Frank Kuwamura, III, San Antonio, TX (US); and Nicholas Cordaro, Vista, CA (US)
Filed on Sep. 28, 2018, as Appl. No. 16/146,301.
Claims priority of provisional application 62/569,526, filed on Oct. 7, 2017.
Prior Publication US 2019/0105432 A1, Apr. 11, 2019
Int. Cl. A61F 2/44 (2006.01); A61M 1/00 (2006.01); A61F 13/00 (2006.01); A61F 2/30 (2006.01)
CPC A61M 1/008 (2013.01) [A61F 2/447 (2013.01); A61F 2/4465 (2013.01); A61F 13/00068 (2013.01); A61M 1/0088 (2013.01); A61F 2002/30593 (2013.01); A61F 2002/30622 (2013.01); A61F 2002/30828 (2013.01); A61M 2205/04 (2013.01); A61M 2210/02 (2013.01); A61M 2210/1003 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An implantable device for providing negative pressure therapy to an internal area of the body comprising:
a body portion, wherein said body portion further comprises a posterior sidewall and an anterior sidewall;
an internal passageway; and
a plurality of openings in an outermost exterior surface of the anterior and posterior sidewalls, wherein said plurality of openings is in fluid communication with the internal passageway and a vacuum source.